234 related articles for article (PubMed ID: 20187227)
1. Evidence in favor of Braak staging of Parkinson's disease.
Dickson DW; Uchikado H; Fujishiro H; Tsuboi Y
Mov Disord; 2010; 25 Suppl 1():S78-82. PubMed ID: 20187227
[TBL] [Abstract][Full Text] [Related]
2. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
3. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
4. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.
Kon T; Tomiyama M; Wakabayashi K
Neuropathology; 2020 Feb; 40(1):30-39. PubMed ID: 31498507
[TBL] [Abstract][Full Text] [Related]
7. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
Uchikado H; Lin WL; DeLucia MW; Dickson DW
J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
[TBL] [Abstract][Full Text] [Related]
9. Formation and development of Lewy pathology: a critical update.
Jellinger KA
J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
[TBL] [Abstract][Full Text] [Related]
10. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
11. Lewy bodies in progressive supranuclear palsy.
Mori H; Oda M; Komori T; Arai N; Takanashi M; Mizutani T; Hirai S; Mizuno Y
Acta Neuropathol; 2002 Sep; 104(3):273-8. PubMed ID: 12172913
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
14. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
16. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
17. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
18. Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.
Toledo JB; Gopal P; Raible K; Irwin DJ; Brettschneider J; Sedor S; Waits K; Boluda S; Grossman M; Van Deerlin VM; Lee EB; Arnold SE; Duda JE; Hurtig H; Lee VM; Adler CH; Beach TG; Trojanowski JQ
Acta Neuropathol; 2016 Mar; 131(3):393-409. PubMed ID: 26721587
[TBL] [Abstract][Full Text] [Related]
19. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
Zaccai J; Brayne C; McKeith I; Matthews F; Ince PG;
Neurology; 2008 Mar; 70(13):1042-8. PubMed ID: 18362284
[TBL] [Abstract][Full Text] [Related]
20. Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.
Mukaetova-Ladinska EB; Xuereb JH; Garcia-Sierra F; Hurt J; Gertz HJ; Hills R; Brayne C; Huppert FA; Paykel ES; McGee MA; Jakes R; Honer WG; Harrington CR; Wischik CM
ScientificWorldJournal; 2009 Dec; 9():1463-75. PubMed ID: 20024519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
